SIBEL BLAU M.D. NPI 1962490797

NPI Information

  • NPI: 1962490797
  • Provider Name: SIBEL BLAU, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 2920 SOUTH MERIDIAN
    SUITE 100
    PUYALLUP, WA
    ZIP 98373
  • Phone: (253) 841-4296

Map and Directions

Get Directions

NPI Details

Sibel Blau, M.D. is a hematology and oncology internal medicine in Puyallup, WA with 39 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Sibel Blau, M.D. NPI is 1962490797. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

2920 SOUTH MERIDIAN
SUITE 100
PUYALLUP, WA
ZIP 98373-428
Phone: (253) 841-4296
Fax: (253) 841-2435

The NPI 1962490797 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS:Q5110)
  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
  • Injection, fulvestrant, 25 mg (HCPCS:J9395)
  • Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg (HCPCS:Q5116)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Bilirubin level, direct (HCPCS:82248)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Transferrin (iron binding protein) level (HCPCS:84466)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Glutamyltransferase (liver enzyme) level (HCPCS:82977)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Cortisol (hormone) measurement, total (HCPCS:82533)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Magnesium level (HCPCS:83735)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Folic acid level, serum (HCPCS:82746)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
  • Unclassified drugs (HCPCS:J3490)
  • Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99439)
  • Phosphate level (HCPCS:84100)
  • Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
  • Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
  • Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
  • Fee covid-19 vac 13 res (HCPCS:0124A)
  • Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
  • Injection, potassium chloride, per 2 meq (HCPCS:J3480)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Red blood count automated, with additional calculations (HCPCS:85046)
  • Uric acid level, blood (HCPCS:84550)
  • Collection of blood sample from implanted device (HCPCS:36591)
  • Adm sarscv2 30mcg trs-sucr b (HCPCS:0054A)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus (HCPCS:87637)
  • Adm sarscov2 30mcg/0.3ml 3rd (HCPCS:0003A)
  • Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage (HCPCS:90686)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Administration of influenza virus vaccine (HCPCS:G0008)

The enumeration date for this NPI number is 10/6/2005 and was last updated on 8/1/2012.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & OncologyMD00037666WASHINGTONYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
18281875MEDICAIDWASHINGTON
2G62251MEDICARE UPIN
3152929OTHERL & I
4AB22376MEDICARE ID-TYPE UNSPECIFIED

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.